TruAlt Bioenergy Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹596Cr
- −34.3% YoY
- −16.4% QoQ
- Net profit
- ₹69Cr
- −38.4% YoY
- 0% QoQ
- Margin
- 22%
- +5 pp YoY
- +3 pp QoQ
Guidance rank: #11 of 22 in Agricultural Food & other Products
See the sector's top 10 — free with your mobile number.
TruAlt Bioenergy Ltd Q4 FY26 key numbers
- Revenue
- Current ethanol sales run rate is 2.2 crore litres/month; expected increase to about 5 crore litres/month once additional 15 crore litres supply from OMCs is implemented.
As stated in TruAlt Bioenergy Ltd's Q4 FY26 earnings call transcript · published 31 May 2026. Reported figures, not investment advice.
The short version
TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.
From TruAlt Bioenergy Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23).
- Current ethanol sales run rate is 2.2 crore litres/month; expected increase to about 5 crore litres/month once additional 15 crore litres supply from OMCs is implemented (Page 5).
- Revenue run rate target from ethanol is around INR 350-400 crores per month if 6 crore litres capacity is utilized (Page 27).
- Execution of 15 crore litres additional ethanol order is pending government/OMC approval, expected after 24-30 months (FY29) (Page 29).
- Exploration of export opportunities and sustainable aviation fuel plans to diversify revenue streams and improve capacity utilization (Pages 5, 23, 29).
2 more points from TruAlt Bioenergy Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what TruAlt Bioenergy Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational.
- They are investing in multiple CBG (Compressed Bio-Gas) plants: 9-10 to be live by current year and 10-15 more planned, funded via a 70:30 debt-to-equity mix.
- Funding includes 51% investment from TruAlt and 49% from JV partners Sumitomo and GAIL, with NABARD loans at favorable interest rates (around 8.65%).
- A fourth CBG plant is planned pending land clearance, aiming for a total of 11 units.
2 more points from TruAlt Bioenergy Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Agricultural Food & other Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what TruAlt Bioenergy Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- TruAlt Bioenergy has existing purchase orders (POs) from private OMCs for about 8 crore litres of ethanol, with only 1.6 crore litres supplied so far; balance 6+ crore litres pending lifting due to delay in indent issuance.
- A court order dated February 4, 2026, mandates OMCs to lift an additional 15 crore litres within three months; this has not been implemented yet due to ongoing litigation involving LTOA holders and OMCs.
- Total expected orderbook for FY 2027 including OMC allocations is approximately 40 crore litres (public + private OMCs) plus pending 15 crore litres from the court order, targeting a peak capacity of around 55 crore litres.
2 more points from TruAlt Bioenergy Ltd's call on order book
Create a free account to keep reading this call
TruAlt Bioenergy Ltd — Quarterly revenue & net profit
TruAlt Bioenergy Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 596 | 907 | -34.3% | 713 | -16.4% |
| Operating profit (EBITDA) | 129 | 154 | -16.2% | 134 | -3.7% |
| Operating margin | 22% | 17% | +5 pp | 19% | +3 pp |
| Profit before tax | 94 | 111 | -15.3% | 90 | +4.4% |
| Net profit (PAT) | 69 | 112 | -38.4% | 69 | 0% |
| EPS (₹) | 7.91 | 15.81 | -50% | 8.08 | -2.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹811 Cr, net profit ₹35 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What TruAlt Bioenergy's management said in earlier quarters
Others in Agricultural Food & other Products this season
- TBI Corn (Q4 FY26)
Current capacity utilization is at 72% of 350 TPD; plans to increase utilization to 96-97% across plants, driving growth (Pages 14, 16). Key concall takeaways…
- Uttam Sugar Mills (Q4 FY26)
Consolidated: ₹471.87 Cr (Q4 FY26) vs ₹569.13 Cr (Q4 FY25), ↓ ~17.1% YoY . Key concall takeaways from Uttam Sugar Mills Ltd's Q4 FY26 earnings call — and how…
- GRM Overseas (Q4 FY26)
597.2 Crores vs. Key concall takeaways from GRM Overseas Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- A C J K Exports (Q4 FY26)
694.7 Cr . Key concall takeaways from Amir Chand Jagdish Kumar (Exports) Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Agricultural Food & other Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
TruAlt Bioenergy Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were TruAlt Bioenergy Ltd Q4 FY26 results?
TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.
What is TruAlt Bioenergy Ltd share price analysis?
TruAlt Bioenergy Ltd currently shows a neutral. The stock trades at a P/E of 25.3 with a market cap of ₹3,958 Cr. Investors should review the full earnings analysis for detailed insights.
Is TruAlt Bioenergy Ltd planning capital expenditure?
TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational.
Keep TruAlt Bioenergy Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
